Nitric oxide-stimulated modification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by (5) (6) (7) (8) . After purification and microsequencing of the radiolabeled protein from human erythrocytes or platelets or rat brain, it was identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) (9-12). Incorporation of radiolabel into isolated GAPDH was also stimulated by NO, meaning that an ADPThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
by free adenosine 5'-diphosphoribose (ADP-ribose) was only 10% of that by NAD. Exposure of GAPDH modified by NAD in the presence of SNP to HgCl2, which acts at thiol linkages, released two products. Both contained nicotinamide and adenylate but did not cochromatograph with NAD. GAPDH activity was inhibited by SNP in a dose-dependent manner in the presence of NAD. When inhibition was 80%, with 1 mM SNP and 1 mM dithiothreitol, covalent modification with NAD was <2%. This result is consistent with the conclusion that inhibition of GAPDH activity by SNP in the presence of NAD is due primarily to active-site nitrosylation, as reported by other workers, and is not due to the minor modification with NAD. These results demonstrate that NO-stimulated modifilcation of GAPDH with NAD is not ADP-ribosylation as previously reported but rather is covalent binding of NAD through a NO-dependent thiol intermediate, possibly providing an example of an unexpected, altered reactivity of a nitrosylated protein.
Nitric oxide (NO) is a cellular mediator with multiple biological functions including smooth muscle relaxation, macrophage-mediated cytotoxicity, and neurotransmission (1) . The intracellular targets regulated by NO are not fully characterized but include the specific activation of guanylate cyclase due to NO coordination to the enzyme heme and nonspecific effects on protein sulfhydryl groups and ironsulfur centers (1, 2) .
ADP-ribosylation is a regulatory protein modification in which the adenosine 5'-diphosphoribose (ADP-ribose) moiety of NAD is transferred from NAD to protein, catalyzed by a family of amino acid-specific ADP-ribosyltransferases, including both bacterial toxins and endogenous cellular enzymes (3, 4) . Recent studies in permeabilized cells or in subcellular fractions demonstrated a NO-stimulated labeling by [adenylate-32P]NAD of a 37-to 41-kDa protein (5) (6) (7) (8) . The modification was interpreted as an ADP-ribosylation resulting from stimulation by NO of an endogenous ADPribosyltransferase (5) (6) (7) (8) . After purification and microsequencing of the radiolabeled protein from human erythrocytes or platelets or rat brain, it was identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12) (9-12). Incorporation of radiolabel into isolated GAPDH was also stimulated by NO, meaning that an ADPThe publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
ribosyltransferase was not needed and suggesting that the protein was automodified (9) (10) (11) (12) (13) . Label was released from GAPDH by treatment with mercuric ion, consistent with the presence of an ADP-ribosylcysteine linkage (9) (10) (11) (12) (13) . The active-site cysteine of GAPDH was suggested to be the site of modification, so that ADP-ribosylation could account for the observed loss of GAPDH activity, even though the extent of modification was very low (=14%) (9-13).
We have now further characterized the GAPDH modification. On the basis of radiolabeling, both the adenine and nicotinamide moieties of NAD were incorporated into the enzyme and released by treatment with Hg2+, indicating that GAPDH was modified covalently with NAD, not with ADPribose.
MATERIALS AND METHODS SDS/PAGE Analysis of Modified GAPDH. Rabbit muscle GAPDH was supplied as a 10 mg-ml-' suspension in 3.2 M (NH4)2SO4 (Boehringer Mannheim). For use in labeling studies, a sample was centrifuged (14,000 x g, 10 min), the supernatant was removed, and the pellet was suspended at 5 mg-ml-' in 0.5 M sodium-Mops (3-morpholinopropanesulfonic acid), pH NAD, 100 mM sodium threitol, and 1 mM EDTA with or with min at 30°C (total vol, 0.1 ml). Labele rated from unbound NAD on PD-10 cc 20 mM sodium Mops (pH 7.5), 100 mM 0.01% Triton X-100. The early protein = 2.75-3.5 ml); this fraction contained protein and <0.001% of the applied free BCA assay, Pierce) and radioactivity ( counting) were measured in this fractiol bound to denatured GAPDH, a sample fraction was made 1% in SDS and heatt 5 min. Protein was precipitated with tr described above and suspended in 1% acetate (pH 6), 1 mM EDTA; samples N assay and determination of radioactivi GAPDH Assay. The activity of GAPE measuring the absorbance at 340 nm product (15 stimulation between the methods was due to a much better separation of bound from free NAD by SDS/PAGE versus chromatography over a de-salting column, resulting in a lower background.
Covalent binding of NAD to GAPDH was stimulated by another NO donor, S-nitrosodithiothreitol (prepared as described in ref. 19) . In an experiment like that of Table 1 , covalent NAD binding in the control (4.0 ± 0.3 mmol of NAD-mol of GAPDH-1) was stimulated 2.2-fold by 1 mM SNP (significance determined by t test; P < 0.0001, n = 6) and 1.7-fold by 1 mM S-nitrosodithiothreitol (P < 0.0001, n = 6).
Radiolabel incorporated into GAPDH was relatively stable in acid and neutral hydroxylamine; 80%o of radiolabel remained, as determined by PhosphorImager analysis. Radiolabel incorporated into GAPDH, however, was sensitive to base (20% remaining) or HgCl2 (10o remaining) (Fig. 2) . This pattern of chemical reactivity is similar to that of ADPribosylcysteine linkages formed by pertussis toxin and NAD in the a subunits ofthe guanine nucleotide-binding regulatory proteins Gi, G., and transducin (20) (21) (22) (23) (24) (25) . Although the GAPDH modification was not ADP-ribosylation, the sensitivity to Hg2+ may still indicate a linkage with a sulflhydryl group. No NAD-thiol linkage was formed in incubations of SNP and NAD with low-molecular-weight thiols (dithiothreitol, cysteine, or N-acetylcysteine), indicating a requirement for the active-site structure of GAPDH.
The (8.5 uCi) in 100 mM sodium Mops, pH 7.0/10 mM EDTA/1 mM dithiothreitol/l mM SNP (total volume, 0.2 ml) for 1 hr at 30°C. Protein was precipitated with trichloroacetic acid and subjected to electrophoresis. The section ofgel between the 28-and 44-kDa prestained standard markers was excised and cut into - on the enzyme. In the absence of HgCl2, little labeled material was released from GAPDH, indicating the modification ofthe protein was fairly stable (Fig. 3 Lower). The released products were not stable in solution, however, as degradation products were observed in the HPLC eluate. Compounds released from GAPDH by treatment with HgCl2 were incubated with snake venom phosphodiesterase. The products, separated by strong anion-exchange HPLC, appeared to be (i) adenosine 5'-monophosphate (retention time = 12 min) and (ii) two nicotinamide-labeled compounds (8 min for one product and 9 min for the other) that did not coelute with nicotinamide (6 min), NAD (10 min), nicotinamide ribose phosphate (19-20 min), or NADH (26-28 min). We tentatively conclude that the compounds released from GAPDH by treatment with Hg2+ were NAD-like molecules altered in the nicotinamide-ribose-phosphate portion. GAPDH is thought to be S-nitrosylated by NO, probably at the active-site cysteine residue (13) . GAPDH activity was inhibited by 1 mM SNP in the presence of dithiothreitol; maximal inhibition was at least 80o at 1 mM dithiothreitol (Fig. 4B) . Either more or less dithiothreitol resulted in less inhibition of GAPDH activity by SNP. Under conditions where inhibition was 80%, labeling was still <2% (Fig. 4A) . Labeling, also, was maximal with 1 mM dithiothreitol in the presence of 1 mM SNP, with less labeling at lower and higher concentrations of dithiothreitol. Dithiothreitol, which is required as a reductant for the release of NO from SNP, may also be required as an intermediate carrier of the NO from SNP to GAPDH, in the form of a nitrosothiol (2, 13, (26) (27) (28) . To determine whether SNP would inhibit GAPDH in the absence of NAD, enzyme exposed to 1 mM SNP/1 mM dithiothreitol for 30 min was passed over a PD-10 desalting column and then assayed without SNP present. Enzyme activity was not significantly inhibited after these treatments, perhaps indicating a limited half-life for the nitrosylated form of GAPDH. We thank Dr. Martha Vaughan for useful discussions and critical review of the data during these studies and Dr. Vincent C. Manganiello for critical review of this manuscript. L.J.M. held a National
